Internal Medicine · Gardena, CA
NPI
1912961939
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
15435 S Western Ave, #201
Gardena, CA, 90249
Phone (310) 515-9871
Groups this clinician bills Medicare through
Medicare paid, 2024
$209K
5,235 services
Medicare patients, 2024
394
Average age 81
Drug cost, 2024
$2.9M
16,282 prescriptions
Company payments, 2025
$1,521
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Larry T Suk was code 99213 (office e&m - established), 1,072 times for 338 patients. In total Larry T Suk billed 5,235 services in 45 codes, and Medicare paid $209K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,072 | 338 | $63.94 | $69K |
| 36415 Venipuncture Blood Collection | Office | 777 | 327 | $8.65 | $6,718 |
| 99441 Telephone Services | Office | 734 | 273 | $23.21 | $17K |
| 99212 Office E&M - Established | Office | 611 | 286 | $38.62 | $24K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 228 | 22 | $37.90 | $8,641 |
| 99458 E&M - Miscellaneous | Office | 222 | 23 | $29.00 | $6,439 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 214 | 214 | $128.33 | $27K |
| 99457 E&M - Miscellaneous | Office | 166 | 23 | $36.34 | $6,032 |
| 96372 Injection Administration | Office | 133 | 66 | $10.41 | $1,384 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 126 | 22 | $49.12 | $6,189 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 120 | 46 | $80.22 | $9,626 |
| 90662 Vaccine Product | Office | 76 | 76 | $73.48 | $5,584 |
| G0008 Administration of influenza virus vaccine | Office | 76 | 76 | $35.02 | $2,662 |
| 96360 Intravenous Infusion, Hydration | Office | 71 | 45 | $25.47 | $1,808 |
| 99214 Office E&M - Established | Office | 67 | 61 | $90.34 | $6,053 |
By year: 2022 $330K for 6,997 services; 2023 $263K for 7,542 services; 2024 $209K for 5,235 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 777 | 327 | $8.65 | $6,718 |
| 82270 Immunoassay | 24 | 24 | $4.29 | $103 |
| 81002 Clinical Chemistry | 12 | 11 | $3.41 | $40.92 |
Medicare prescription drug claims, 2024
In 2024, the drug Larry T Suk prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,072 prescriptions and refills. In total Larry T Suk wrote 16,282 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,072 | 2,982 | 315 | $7,951 |
| Vascepa Icosapent Ethyl | 773 | 965 | 150 | $333K |
| Losartan Potassium Generic | 643 | 1,745 | 176 | $4,822 |
| Amlodipine Besylate Generic | 641 | 1,708 | 169 | $2,912 |
| Lidocaine Generic | 548 | 646 | 100 | $128K |
| Metformin Hcl Generic | 493 | 1,301 | 136 | $3,131 |
| Omeprazole Generic | 492 | 1,136 | 196 | $3,880 |
| Levothyroxine Sodium Generic | 477 | 1,304 | 122 | $6,112 |
| Creon Lipase/Protease/Amylase | 431 | 493 | 123 | $438K |
| Linzess Linaclotide | 406 | 486 | 93 | $252K |
| Tamsulosin Hcl Generic | 315 | 783 | 90 | $2,926 |
| Icosapent Ethyl Generic | 298 | 435 | 107 | $58K |
| Trulicity Dulaglutide | 298 | 346 | 37 | $325K |
| Azithromycin Generic | 294 | 294 | 212 | $875 |
| Jardiance Empagliflozin | 293 | 394 | 44 | $225K |
Brand drugs: 3,963 claims; generic drugs: 12,210 claims; opioid claims: 182.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Larry T Suk $1,521 ($1,521 in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $392.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $392 |
| Abbvie Inc. ABBV | 17 | $255 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $188 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $141 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $116 |
| Insmed, Inc. INSM | 4 | $91.07 |
| Lilly USA, LLC LLY | 3 | $84.07 |
| Exact Sciences Corporation EXAS | 3 | $78.83 |
| Shield Therapeutics Inc STX.L | 1 | $30.87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.32 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.